|
1) Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998; 339: 1979-84
|
|
|
|
2) Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet. 2002; 359: 1727-33
|
|
|
|
|
|
3) Malthaner RA, Colin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev. 2006; 3: CD001556
|
|
|
|
|
|
4) Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992; 326: 1593-8
|
|
|
|
|
|
5) Ohtsu A. Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol. 2004; 9: 444-50
|
|
|
|
|
6) Minsky BD, Neugerg D, Kelse DP, et al. Final report of intergroupTrial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Bio Phys. 1999; 43: 517-23
|
|
|
|
|
|
7) Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003; 21: 2697-702
|
|
|
|
|
|
8) Walsh TN, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinomas. N Engl J Med. 1996; 335: 462-7
|
|
|
|
|
|
9) Urba SG, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001; 19: 305-13
|
|
|
|
|
|
10) Burmeister BH, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomized controlled phase III trial. Lancet Oncol. 2005; 6: 659-68
|
|
|
|
|
|
11) Mariette C, Piessen G, Lamblin A, et al. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg. 2006; 93: 1077-83
|
|
|
|
|
|
12) Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008; 26: 1086-92
|
|
|
|
|
|
13) Morgan MA, Lewis WG, Crosby TD, et al. Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer. Br J Surg. 2007; 94: 1509-14
|
|
|
|
|
|
14) Luu TD, Gaur P, Force SD, et al. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann Thorac Surg. 2008; 85: 1217-23
|
|
|
|
|
|
15) Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007; 8: 226-34
|
|
|
|
|
|
16) Kato H, Udagawa H, Togo A, et al. A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma: the Japan Clinical Oncology Group study (JCOG9708). Proc Am Soc Clin Oncol. 2003; 21: 286a (abstract 1147)
|
|
|
|
|
|
17) Hironaka S, Ohtsu A, Boku N, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003; 57: 425-33
|
|
|
|
|
|
18) Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005; 23: 2310-7
|
|
|
|
|
|
19) Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25: 1160-8
|
|
|
|
|
|
20) Swisher SG, Wynn P, Le Prise E, et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg. 2002; 123: 175-83
|
|
|
|
|
|
21) Smithers BM, Cullinan M, Thomas JM, et al. Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Dis Esophagus. 2007; 20: 471-7
|
|
|
|
|
|
22) Chao YK, Chan SC, Chang HK, et al. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol. 2008; Apr 5. [Epub ahead of print]
|
|
|
|
|
|
23) Reynolds JV, Ravi N, Hollywood D, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2006; 132: 549-55
|
|
|
|
|
|
24) Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg. 2007; 94: 1059-66
|
|
|
|
|
|
25) Nakamura T, Hayashi K, Ota M, et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg. 2004; 188: 261-6
|
|
|
|
|
|
26) Piessen G, Briez N, Triboulet JP, et al. Patients with locally advanced esophageal carcinoma nonresponder to radiochemothrapy: who will benefit from surgery？ Ann Surg Oncol. 2007; 14: 2036-44
|
|
|
|
|
|
27) Hokamura N, Tachimori Y. Salvage surgery after definitive chemoradiation for esophageal carcinoma. Nippon Geka Gakkai Zasshi. 2008; 109: 31-5
|
|
|
|
|
|
28) Urschel JD, Sellke FW. Complications of salvage esophagectomy. Med Sci Moint. 2003; 9: RA173-80
|
|
|
|
|
|
29) Munden RF, Macapinlac HA, Erasmus JJ. Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy. J Thorac Imaging. 2006; 21: 137-45
|
|
|
|
|
|
30) van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004; 18: 3805-12
|
|
|
|
|
|
31) Levine EA, Farmer MR, Clark P, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg. 2006; 243: 472-8
|
|
|
|
|
|
32) Schneider BJ, Urba SG. Preoperative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care？ Semin Radiat Oncol. 2007; 17: 45-52
|
|
|
|
|